D
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Price:
10.54
USD
0.24%
Market Closed
Market Cap:
$353.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
US |
|
O
|
Oriental Precision & Engineering Co Ltd
KOSDAQ:014940
|
KR |
|
Transgene SA
PAR:TNG
|
FR |
|
Cantor Equity Partners Inc
NASDAQ:CEP
|
US |
|
Miliboo SA
PAR:ALMLB
|
FR |
Income Statement
Earnings Waterfall
Drugs Made In America Acquisition Corp
Drugs Made In America Acquisition Corp
Income Statement
Drugs Made In America Acquisition Corp
Drugs Made In America Acquisition Corp
Currency: USD
| Jun-2025 | Sep-2025 | ||
|---|---|---|---|
| Revenue | |||
| Revenue |
0
N/A
|
0
N/A
|
|
| Operating Income | |||
| Operating Expenses |
(1)
|
(1)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
|
| Operating Income |
(1)
N/A
|
(1)
-36%
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
4
|
6
|
|
| Pre-Tax Income |
3
N/A
|
5
+67%
|
|
| Net Income | |||
| Income from Continuing Operations |
3
|
5
|
|
| Net Income (Common) |
3
N/A
|
5
+67%
|
|
| EPS (Diluted) |
0.09
N/A
|
0.16
+78%
|
|
Switch to:
Switch to:
See Also
Discover More
